nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A4—breast cancer	0.148	0.546	CbGaD
Rivaroxaban—ABCB1—breast cancer	0.123	0.454	CbGaD
Rivaroxaban—CYP3A5—Lapatinib—breast cancer	0.0348	0.0809	CbGbCtD
Rivaroxaban—ABCB1—Toremifene—breast cancer	0.031	0.0721	CbGbCtD
Rivaroxaban—CYP3A4—Exemestane—breast cancer	0.0268	0.0624	CbGbCtD
Rivaroxaban—CYP3A4—Letrozole—breast cancer	0.0228	0.053	CbGbCtD
Rivaroxaban—ABCB1—Lapatinib—breast cancer	0.0226	0.0526	CbGbCtD
Rivaroxaban—CYP3A4—Anastrozole—breast cancer	0.0203	0.0473	CbGbCtD
Rivaroxaban—CYP3A4—Toremifene—breast cancer	0.0186	0.0432	CbGbCtD
Rivaroxaban—CYP3A5—Tamoxifen—breast cancer	0.0174	0.0405	CbGbCtD
Rivaroxaban—CYP3A4—Fulvestrant—breast cancer	0.0173	0.0402	CbGbCtD
Rivaroxaban—CYP3A4—Thiotepa—breast cancer	0.0154	0.0358	CbGbCtD
Rivaroxaban—CYP3A4—Ixabepilone—breast cancer	0.0141	0.0328	CbGbCtD
Rivaroxaban—CYP3A4—Lapatinib—breast cancer	0.0136	0.0315	CbGbCtD
Rivaroxaban—CYP3A5—Paclitaxel—breast cancer	0.0136	0.0315	CbGbCtD
Rivaroxaban—CYP3A5—Irinotecan—breast cancer	0.0134	0.0311	CbGbCtD
Rivaroxaban—ABCB1—Vinorelbine—breast cancer	0.0126	0.0292	CbGbCtD
Rivaroxaban—ABCB1—Tamoxifen—breast cancer	0.0113	0.0264	CbGbCtD
Rivaroxaban—ABCB1—Mitoxantrone—breast cancer	0.0111	0.0257	CbGbCtD
Rivaroxaban—CYP3A4—Raloxifene—breast cancer	0.0103	0.0239	CbGbCtD
Rivaroxaban—CYP3A5—Docetaxel—breast cancer	0.0098	0.0228	CbGbCtD
Rivaroxaban—ABCB1—Gemcitabine—breast cancer	0.00976	0.0227	CbGbCtD
Rivaroxaban—ABCB1—Paclitaxel—breast cancer	0.00882	0.0205	CbGbCtD
Rivaroxaban—ABCB1—Irinotecan—breast cancer	0.0087	0.0202	CbGbCtD
Rivaroxaban—ABCB1—Vinblastine—breast cancer	0.00774	0.018	CbGbCtD
Rivaroxaban—CYP3A4—Vinorelbine—breast cancer	0.00752	0.0175	CbGbCtD
Rivaroxaban—CYP3A4—Tamoxifen—breast cancer	0.00679	0.0158	CbGbCtD
Rivaroxaban—CYP3A4—Mitoxantrone—breast cancer	0.00662	0.0154	CbGbCtD
Rivaroxaban—ABCB1—Docetaxel—breast cancer	0.00638	0.0148	CbGbCtD
Rivaroxaban—CYP3A4—Paclitaxel—breast cancer	0.00528	0.0123	CbGbCtD
Rivaroxaban—CYP3A4—Irinotecan—breast cancer	0.00521	0.0121	CbGbCtD
Rivaroxaban—ABCB1—Doxorubicin—breast cancer	0.00475	0.0111	CbGbCtD
Rivaroxaban—CYP3A4—Vinblastine—breast cancer	0.00463	0.0108	CbGbCtD
Rivaroxaban—ABCB1—Methotrexate—breast cancer	0.0046	0.0107	CbGbCtD
Rivaroxaban—CYP3A4—Docetaxel—breast cancer	0.00382	0.00889	CbGbCtD
Rivaroxaban—F10—mammary gland—breast cancer	0.00344	0.114	CbGeAlD
Rivaroxaban—F10—nipple—breast cancer	0.00285	0.0943	CbGeAlD
Rivaroxaban—CYP3A4—Doxorubicin—breast cancer	0.00285	0.00662	CbGbCtD
Rivaroxaban—CYP2J2—nipple—breast cancer	0.00233	0.0773	CbGeAlD
Rivaroxaban—F10—endometrium—breast cancer	0.00172	0.0569	CbGeAlD
Rivaroxaban—F10—adipose tissue—breast cancer	0.00155	0.0513	CbGeAlD
Rivaroxaban—CYP2J2—skin of body—breast cancer	0.00149	0.0495	CbGeAlD
Rivaroxaban—F10—female reproductive system—breast cancer	0.00142	0.0472	CbGeAlD
Rivaroxaban—CYP2J2—endometrium—breast cancer	0.00141	0.0467	CbGeAlD
Rivaroxaban—F10—adrenal gland—breast cancer	0.00139	0.046	CbGeAlD
Rivaroxaban—CYP2J2—uterus—breast cancer	0.0013	0.043	CbGeAlD
Rivaroxaban—F10—female gonad—breast cancer	0.0013	0.0429	CbGeAlD
Rivaroxaban—CYP2J2—pituitary gland—breast cancer	0.00128	0.0422	CbGeAlD
Rivaroxaban—F10—endocrine gland—breast cancer	0.00121	0.0399	CbGeAlD
Rivaroxaban—CYP2J2—female reproductive system—breast cancer	0.00117	0.0387	CbGeAlD
Rivaroxaban—CYP2J2—endocrine gland—breast cancer	0.000988	0.0327	CbGeAlD
Rivaroxaban—F10—lymph node—breast cancer	0.000833	0.0276	CbGeAlD
Rivaroxaban—CYP3A5—adipose tissue—breast cancer	0.000447	0.0148	CbGeAlD
Rivaroxaban—CYP3A5—female gonad—breast cancer	0.000374	0.0124	CbGeAlD
Rivaroxaban—ABCB1—embryo—breast cancer	0.00036	0.0119	CbGeAlD
Rivaroxaban—CYP3A5—endocrine gland—breast cancer	0.000348	0.0115	CbGeAlD
Rivaroxaban—CYP3A4—female reproductive system—breast cancer	0.000308	0.0102	CbGeAlD
Rivaroxaban—ABCB1—epithelium—breast cancer	0.000294	0.00973	CbGeAlD
Rivaroxaban—ABCB1—endometrium—breast cancer	0.000264	0.00872	CbGeAlD
Rivaroxaban—CYP3A4—endocrine gland—breast cancer	0.000261	0.00864	CbGeAlD
Rivaroxaban—ABCB1—uterus—breast cancer	0.000243	0.00804	CbGeAlD
Rivaroxaban—ABCB1—pituitary gland—breast cancer	0.000238	0.00789	CbGeAlD
Rivaroxaban—ABCB1—adipose tissue—breast cancer	0.000237	0.00786	CbGeAlD
Rivaroxaban—ABCB1—female reproductive system—breast cancer	0.000218	0.00723	CbGeAlD
Rivaroxaban—ABCB1—adrenal gland—breast cancer	0.000213	0.00705	CbGeAlD
Rivaroxaban—ABCB1—bone marrow—breast cancer	0.000206	0.00682	CbGeAlD
Rivaroxaban—ABCB1—female gonad—breast cancer	0.000199	0.00658	CbGeAlD
Rivaroxaban—ABCB1—endocrine gland—breast cancer	0.000185	0.00612	CbGeAlD
Rivaroxaban—ABCB1—lymph node—breast cancer	0.000128	0.00423	CbGeAlD
Rivaroxaban—Epistaxis—Epirubicin—breast cancer	5.5e-05	0.000307	CcSEcCtD
Rivaroxaban—Pruritus—Gemcitabine—breast cancer	5.5e-05	0.000307	CcSEcCtD
Rivaroxaban—Nausea—Thiotepa—breast cancer	5.49e-05	0.000306	CcSEcCtD
Rivaroxaban—Urethral disorder—Methotrexate—breast cancer	5.49e-05	0.000306	CcSEcCtD
Rivaroxaban—Infection—Docetaxel—breast cancer	5.48e-05	0.000305	CcSEcCtD
Rivaroxaban—Sinusitis—Epirubicin—breast cancer	5.47e-05	0.000305	CcSEcCtD
Rivaroxaban—Diarrhoea—Mitoxantrone—breast cancer	5.46e-05	0.000304	CcSEcCtD
Rivaroxaban—Diarrhoea—Irinotecan—breast cancer	5.46e-05	0.000304	CcSEcCtD
Rivaroxaban—Dry mouth—Capecitabine—breast cancer	5.45e-05	0.000304	CcSEcCtD
Rivaroxaban—Agranulocytosis—Epirubicin—breast cancer	5.44e-05	0.000303	CcSEcCtD
Rivaroxaban—Shock—Docetaxel—breast cancer	5.43e-05	0.000302	CcSEcCtD
Rivaroxaban—Nervous system disorder—Docetaxel—breast cancer	5.41e-05	0.000302	CcSEcCtD
Rivaroxaban—Pruritus—Fluorouracil—breast cancer	5.41e-05	0.000301	CcSEcCtD
Rivaroxaban—Infestation NOS—Doxorubicin—breast cancer	5.4e-05	0.000301	CcSEcCtD
Rivaroxaban—Infestation—Doxorubicin—breast cancer	5.4e-05	0.000301	CcSEcCtD
Rivaroxaban—Tachycardia—Docetaxel—breast cancer	5.38e-05	0.0003	CcSEcCtD
Rivaroxaban—Feeling abnormal—Paclitaxel—breast cancer	5.36e-05	0.000299	CcSEcCtD
Rivaroxaban—Skin disorder—Docetaxel—breast cancer	5.36e-05	0.000299	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Doxorubicin—breast cancer	5.35e-05	0.000298	CcSEcCtD
Rivaroxaban—Oedema—Capecitabine—breast cancer	5.34e-05	0.000298	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Paclitaxel—breast cancer	5.32e-05	0.000297	CcSEcCtD
Rivaroxaban—Diarrhoea—Gemcitabine—breast cancer	5.32e-05	0.000296	CcSEcCtD
Rivaroxaban—Renal failure—Doxorubicin—breast cancer	5.31e-05	0.000296	CcSEcCtD
Rivaroxaban—Infection—Capecitabine—breast cancer	5.31e-05	0.000296	CcSEcCtD
Rivaroxaban—Erythema multiforme—Methotrexate—breast cancer	5.29e-05	0.000295	CcSEcCtD
Rivaroxaban—Dizziness—Irinotecan—breast cancer	5.28e-05	0.000294	CcSEcCtD
Rivaroxaban—Haemoglobin—Epirubicin—breast cancer	5.26e-05	0.000293	CcSEcCtD
Rivaroxaban—Jaundice—Doxorubicin—breast cancer	5.26e-05	0.000293	CcSEcCtD
Rivaroxaban—Shock—Capecitabine—breast cancer	5.26e-05	0.000293	CcSEcCtD
Rivaroxaban—Urinary tract infection—Doxorubicin—breast cancer	5.25e-05	0.000292	CcSEcCtD
Rivaroxaban—Nervous system disorder—Capecitabine—breast cancer	5.24e-05	0.000292	CcSEcCtD
Rivaroxaban—Haemorrhage—Epirubicin—breast cancer	5.24e-05	0.000292	CcSEcCtD
Rivaroxaban—Hepatitis—Epirubicin—breast cancer	5.24e-05	0.000292	CcSEcCtD
Rivaroxaban—Eye disorder—Methotrexate—breast cancer	5.23e-05	0.000291	CcSEcCtD
Rivaroxaban—Diarrhoea—Fluorouracil—breast cancer	5.23e-05	0.000291	CcSEcCtD
Rivaroxaban—Tachycardia—Capecitabine—breast cancer	5.21e-05	0.000291	CcSEcCtD
Rivaroxaban—Cardiac disorder—Methotrexate—breast cancer	5.19e-05	0.000289	CcSEcCtD
Rivaroxaban—Skin disorder—Capecitabine—breast cancer	5.19e-05	0.000289	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Epirubicin—breast cancer	5.17e-05	0.000288	CcSEcCtD
Rivaroxaban—Urticaria—Paclitaxel—breast cancer	5.17e-05	0.000288	CcSEcCtD
Rivaroxaban—Hypotension—Docetaxel—breast cancer	5.16e-05	0.000287	CcSEcCtD
Rivaroxaban—Haematuria—Doxorubicin—breast cancer	5.15e-05	0.000287	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Epirubicin—breast cancer	5.15e-05	0.000287	CcSEcCtD
Rivaroxaban—Abdominal pain—Paclitaxel—breast cancer	5.15e-05	0.000287	CcSEcCtD
Rivaroxaban—Urethral disorder—Epirubicin—breast cancer	5.13e-05	0.000286	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Doxorubicin—breast cancer	5.11e-05	0.000285	CcSEcCtD
Rivaroxaban—Epistaxis—Doxorubicin—breast cancer	5.09e-05	0.000284	CcSEcCtD
Rivaroxaban—Angiopathy—Methotrexate—breast cancer	5.08e-05	0.000283	CcSEcCtD
Rivaroxaban—Vomiting—Irinotecan—breast cancer	5.07e-05	0.000283	CcSEcCtD
Rivaroxaban—Vomiting—Mitoxantrone—breast cancer	5.07e-05	0.000283	CcSEcCtD
Rivaroxaban—Sinusitis—Doxorubicin—breast cancer	5.06e-05	0.000282	CcSEcCtD
Rivaroxaban—Immune system disorder—Methotrexate—breast cancer	5.06e-05	0.000282	CcSEcCtD
Rivaroxaban—Dizziness—Fluorouracil—breast cancer	5.05e-05	0.000282	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Methotrexate—breast cancer	5.04e-05	0.000281	CcSEcCtD
Rivaroxaban—Agranulocytosis—Doxorubicin—breast cancer	5.04e-05	0.000281	CcSEcCtD
Rivaroxaban—Rash—Mitoxantrone—breast cancer	5.03e-05	0.00028	CcSEcCtD
Rivaroxaban—Rash—Irinotecan—breast cancer	5.03e-05	0.00028	CcSEcCtD
Rivaroxaban—Dermatitis—Irinotecan—breast cancer	5.03e-05	0.00028	CcSEcCtD
Rivaroxaban—Dermatitis—Mitoxantrone—breast cancer	5.03e-05	0.00028	CcSEcCtD
Rivaroxaban—Headache—Irinotecan—breast cancer	5e-05	0.000279	CcSEcCtD
Rivaroxaban—Headache—Mitoxantrone—breast cancer	5e-05	0.000279	CcSEcCtD
Rivaroxaban—Hypotension—Capecitabine—breast cancer	4.99e-05	0.000278	CcSEcCtD
Rivaroxaban—Erythema multiforme—Epirubicin—breast cancer	4.95e-05	0.000276	CcSEcCtD
Rivaroxaban—Vomiting—Gemcitabine—breast cancer	4.94e-05	0.000275	CcSEcCtD
Rivaroxaban—Dyspnoea—Docetaxel—breast cancer	4.92e-05	0.000274	CcSEcCtD
Rivaroxaban—Rash—Gemcitabine—breast cancer	4.9e-05	0.000273	CcSEcCtD
Rivaroxaban—Dermatitis—Gemcitabine—breast cancer	4.9e-05	0.000273	CcSEcCtD
Rivaroxaban—Eye disorder—Epirubicin—breast cancer	4.89e-05	0.000273	CcSEcCtD
Rivaroxaban—Haemoglobin—Doxorubicin—breast cancer	4.87e-05	0.000271	CcSEcCtD
Rivaroxaban—Headache—Gemcitabine—breast cancer	4.87e-05	0.000271	CcSEcCtD
Rivaroxaban—Cardiac disorder—Epirubicin—breast cancer	4.86e-05	0.000271	CcSEcCtD
Rivaroxaban—Vomiting—Fluorouracil—breast cancer	4.86e-05	0.000271	CcSEcCtD
Rivaroxaban—Dyspepsia—Docetaxel—breast cancer	4.86e-05	0.000271	CcSEcCtD
Rivaroxaban—Haemorrhage—Doxorubicin—breast cancer	4.85e-05	0.00027	CcSEcCtD
Rivaroxaban—Hepatitis—Doxorubicin—breast cancer	4.85e-05	0.00027	CcSEcCtD
Rivaroxaban—Rash—Fluorouracil—breast cancer	4.82e-05	0.000269	CcSEcCtD
Rivaroxaban—Dermatitis—Fluorouracil—breast cancer	4.82e-05	0.000268	CcSEcCtD
Rivaroxaban—Hypersensitivity—Paclitaxel—breast cancer	4.8e-05	0.000267	CcSEcCtD
Rivaroxaban—Headache—Fluorouracil—breast cancer	4.79e-05	0.000267	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Doxorubicin—breast cancer	4.79e-05	0.000267	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Docetaxel—breast cancer	4.76e-05	0.000265	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Doxorubicin—breast cancer	4.76e-05	0.000265	CcSEcCtD
Rivaroxaban—Dyspnoea—Capecitabine—breast cancer	4.76e-05	0.000265	CcSEcCtD
Rivaroxaban—Fatigue—Docetaxel—breast cancer	4.76e-05	0.000265	CcSEcCtD
Rivaroxaban—Angiopathy—Epirubicin—breast cancer	4.75e-05	0.000265	CcSEcCtD
Rivaroxaban—Urethral disorder—Doxorubicin—breast cancer	4.75e-05	0.000265	CcSEcCtD
Rivaroxaban—Nausea—Mitoxantrone—breast cancer	4.74e-05	0.000264	CcSEcCtD
Rivaroxaban—Nausea—Irinotecan—breast cancer	4.74e-05	0.000264	CcSEcCtD
Rivaroxaban—Immune system disorder—Epirubicin—breast cancer	4.73e-05	0.000264	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Epirubicin—breast cancer	4.72e-05	0.000263	CcSEcCtD
Rivaroxaban—Constipation—Docetaxel—breast cancer	4.72e-05	0.000263	CcSEcCtD
Rivaroxaban—Pain—Docetaxel—breast cancer	4.72e-05	0.000263	CcSEcCtD
Rivaroxaban—Back pain—Methotrexate—breast cancer	4.71e-05	0.000263	CcSEcCtD
Rivaroxaban—Dyspepsia—Capecitabine—breast cancer	4.7e-05	0.000262	CcSEcCtD
Rivaroxaban—Asthenia—Paclitaxel—breast cancer	4.67e-05	0.00026	CcSEcCtD
Rivaroxaban—Nausea—Gemcitabine—breast cancer	4.62e-05	0.000257	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Capecitabine—breast cancer	4.61e-05	0.000257	CcSEcCtD
Rivaroxaban—Fatigue—Capecitabine—breast cancer	4.61e-05	0.000257	CcSEcCtD
Rivaroxaban—Pruritus—Paclitaxel—breast cancer	4.61e-05	0.000257	CcSEcCtD
Rivaroxaban—Erythema multiforme—Doxorubicin—breast cancer	4.58e-05	0.000255	CcSEcCtD
Rivaroxaban—Constipation—Capecitabine—breast cancer	4.57e-05	0.000255	CcSEcCtD
Rivaroxaban—Pain—Capecitabine—breast cancer	4.57e-05	0.000255	CcSEcCtD
Rivaroxaban—Feeling abnormal—Docetaxel—breast cancer	4.55e-05	0.000253	CcSEcCtD
Rivaroxaban—Nausea—Fluorouracil—breast cancer	4.54e-05	0.000253	CcSEcCtD
Rivaroxaban—Eye disorder—Doxorubicin—breast cancer	4.53e-05	0.000252	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Methotrexate—breast cancer	4.52e-05	0.000252	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Docetaxel—breast cancer	4.51e-05	0.000251	CcSEcCtD
Rivaroxaban—Anaemia—Methotrexate—breast cancer	4.5e-05	0.000251	CcSEcCtD
Rivaroxaban—Cardiac disorder—Doxorubicin—breast cancer	4.5e-05	0.000251	CcSEcCtD
Rivaroxaban—Diarrhoea—Paclitaxel—breast cancer	4.45e-05	0.000248	CcSEcCtD
Rivaroxaban—Back pain—Epirubicin—breast cancer	4.41e-05	0.000246	CcSEcCtD
Rivaroxaban—Feeling abnormal—Capecitabine—breast cancer	4.4e-05	0.000245	CcSEcCtD
Rivaroxaban—Angiopathy—Doxorubicin—breast cancer	4.4e-05	0.000245	CcSEcCtD
Rivaroxaban—Malaise—Methotrexate—breast cancer	4.39e-05	0.000245	CcSEcCtD
Rivaroxaban—Muscle spasms—Epirubicin—breast cancer	4.38e-05	0.000244	CcSEcCtD
Rivaroxaban—Immune system disorder—Doxorubicin—breast cancer	4.38e-05	0.000244	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Capecitabine—breast cancer	4.37e-05	0.000243	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Doxorubicin—breast cancer	4.37e-05	0.000243	CcSEcCtD
Rivaroxaban—Abdominal pain—Docetaxel—breast cancer	4.36e-05	0.000243	CcSEcCtD
Rivaroxaban—Dizziness—Paclitaxel—breast cancer	4.3e-05	0.00024	CcSEcCtD
Rivaroxaban—Urticaria—Capecitabine—breast cancer	4.24e-05	0.000236	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Epirubicin—breast cancer	4.23e-05	0.000236	CcSEcCtD
Rivaroxaban—Abdominal pain—Capecitabine—breast cancer	4.22e-05	0.000235	CcSEcCtD
Rivaroxaban—Anaemia—Epirubicin—breast cancer	4.21e-05	0.000235	CcSEcCtD
Rivaroxaban—Chest pain—Methotrexate—breast cancer	4.15e-05	0.000231	CcSEcCtD
Rivaroxaban—Vomiting—Paclitaxel—breast cancer	4.14e-05	0.000231	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.12e-05	0.00023	CcSEcCtD
Rivaroxaban—Malaise—Epirubicin—breast cancer	4.11e-05	0.000229	CcSEcCtD
Rivaroxaban—Rash—Paclitaxel—breast cancer	4.1e-05	0.000229	CcSEcCtD
Rivaroxaban—Dermatitis—Paclitaxel—breast cancer	4.1e-05	0.000228	CcSEcCtD
Rivaroxaban—Discomfort—Methotrexate—breast cancer	4.1e-05	0.000228	CcSEcCtD
Rivaroxaban—Syncope—Epirubicin—breast cancer	4.09e-05	0.000228	CcSEcCtD
Rivaroxaban—Back pain—Doxorubicin—breast cancer	4.08e-05	0.000227	CcSEcCtD
Rivaroxaban—Headache—Paclitaxel—breast cancer	4.08e-05	0.000227	CcSEcCtD
Rivaroxaban—Hypersensitivity—Docetaxel—breast cancer	4.06e-05	0.000227	CcSEcCtD
Rivaroxaban—Muscle spasms—Doxorubicin—breast cancer	4.06e-05	0.000226	CcSEcCtD
Rivaroxaban—Loss of consciousness—Epirubicin—breast cancer	4.01e-05	0.000223	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Methotrexate—breast cancer	3.98e-05	0.000222	CcSEcCtD
Rivaroxaban—Asthenia—Docetaxel—breast cancer	3.96e-05	0.000221	CcSEcCtD
Rivaroxaban—Infection—Methotrexate—breast cancer	3.95e-05	0.00022	CcSEcCtD
Rivaroxaban—Hypersensitivity—Capecitabine—breast cancer	3.94e-05	0.000219	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Doxorubicin—breast cancer	3.91e-05	0.000218	CcSEcCtD
Rivaroxaban—Pruritus—Docetaxel—breast cancer	3.9e-05	0.000218	CcSEcCtD
Rivaroxaban—Nervous system disorder—Methotrexate—breast cancer	3.9e-05	0.000217	CcSEcCtD
Rivaroxaban—Anaemia—Doxorubicin—breast cancer	3.9e-05	0.000217	CcSEcCtD
Rivaroxaban—Chest pain—Epirubicin—breast cancer	3.88e-05	0.000216	CcSEcCtD
Rivaroxaban—Nausea—Paclitaxel—breast cancer	3.87e-05	0.000215	CcSEcCtD
Rivaroxaban—Skin disorder—Methotrexate—breast cancer	3.86e-05	0.000215	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.86e-05	0.000215	CcSEcCtD
Rivaroxaban—Discomfort—Epirubicin—breast cancer	3.84e-05	0.000214	CcSEcCtD
Rivaroxaban—Asthenia—Capecitabine—breast cancer	3.83e-05	0.000214	CcSEcCtD
Rivaroxaban—Malaise—Doxorubicin—breast cancer	3.8e-05	0.000212	CcSEcCtD
Rivaroxaban—Dry mouth—Epirubicin—breast cancer	3.8e-05	0.000212	CcSEcCtD
Rivaroxaban—Syncope—Doxorubicin—breast cancer	3.78e-05	0.000211	CcSEcCtD
Rivaroxaban—Pruritus—Capecitabine—breast cancer	3.78e-05	0.000211	CcSEcCtD
Rivaroxaban—Diarrhoea—Docetaxel—breast cancer	3.77e-05	0.00021	CcSEcCtD
Rivaroxaban—Oedema—Epirubicin—breast cancer	3.72e-05	0.000207	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Epirubicin—breast cancer	3.72e-05	0.000207	CcSEcCtD
Rivaroxaban—Hypotension—Methotrexate—breast cancer	3.72e-05	0.000207	CcSEcCtD
Rivaroxaban—Loss of consciousness—Doxorubicin—breast cancer	3.71e-05	0.000207	CcSEcCtD
Rivaroxaban—Infection—Epirubicin—breast cancer	3.7e-05	0.000206	CcSEcCtD
Rivaroxaban—Shock—Epirubicin—breast cancer	3.66e-05	0.000204	CcSEcCtD
Rivaroxaban—Diarrhoea—Capecitabine—breast cancer	3.65e-05	0.000204	CcSEcCtD
Rivaroxaban—Nervous system disorder—Epirubicin—breast cancer	3.65e-05	0.000203	CcSEcCtD
Rivaroxaban—Dizziness—Docetaxel—breast cancer	3.65e-05	0.000203	CcSEcCtD
Rivaroxaban—Tachycardia—Epirubicin—breast cancer	3.63e-05	0.000202	CcSEcCtD
Rivaroxaban—Skin disorder—Epirubicin—breast cancer	3.61e-05	0.000201	CcSEcCtD
Rivaroxaban—Chest pain—Doxorubicin—breast cancer	3.59e-05	0.0002	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.57e-05	0.000199	CcSEcCtD
Rivaroxaban—Discomfort—Doxorubicin—breast cancer	3.55e-05	0.000198	CcSEcCtD
Rivaroxaban—Dyspnoea—Methotrexate—breast cancer	3.55e-05	0.000198	CcSEcCtD
Rivaroxaban—Dizziness—Capecitabine—breast cancer	3.53e-05	0.000197	CcSEcCtD
Rivaroxaban—Dry mouth—Doxorubicin—breast cancer	3.51e-05	0.000196	CcSEcCtD
Rivaroxaban—Vomiting—Docetaxel—breast cancer	3.51e-05	0.000195	CcSEcCtD
Rivaroxaban—Dyspepsia—Methotrexate—breast cancer	3.5e-05	0.000195	CcSEcCtD
Rivaroxaban—Rash—Docetaxel—breast cancer	3.48e-05	0.000194	CcSEcCtD
Rivaroxaban—Hypotension—Epirubicin—breast cancer	3.48e-05	0.000194	CcSEcCtD
Rivaroxaban—Dermatitis—Docetaxel—breast cancer	3.48e-05	0.000194	CcSEcCtD
Rivaroxaban—Headache—Docetaxel—breast cancer	3.46e-05	0.000193	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Doxorubicin—breast cancer	3.44e-05	0.000192	CcSEcCtD
Rivaroxaban—Oedema—Doxorubicin—breast cancer	3.44e-05	0.000192	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Methotrexate—breast cancer	3.43e-05	0.000191	CcSEcCtD
Rivaroxaban—Fatigue—Methotrexate—breast cancer	3.43e-05	0.000191	CcSEcCtD
Rivaroxaban—Infection—Doxorubicin—breast cancer	3.42e-05	0.000191	CcSEcCtD
Rivaroxaban—Pain—Methotrexate—breast cancer	3.4e-05	0.000189	CcSEcCtD
Rivaroxaban—Vomiting—Capecitabine—breast cancer	3.4e-05	0.000189	CcSEcCtD
Rivaroxaban—Shock—Doxorubicin—breast cancer	3.39e-05	0.000189	CcSEcCtD
Rivaroxaban—Nervous system disorder—Doxorubicin—breast cancer	3.38e-05	0.000188	CcSEcCtD
Rivaroxaban—Rash—Capecitabine—breast cancer	3.37e-05	0.000188	CcSEcCtD
Rivaroxaban—Dermatitis—Capecitabine—breast cancer	3.36e-05	0.000188	CcSEcCtD
Rivaroxaban—Tachycardia—Doxorubicin—breast cancer	3.36e-05	0.000187	CcSEcCtD
Rivaroxaban—Headache—Capecitabine—breast cancer	3.35e-05	0.000186	CcSEcCtD
Rivaroxaban—Skin disorder—Doxorubicin—breast cancer	3.34e-05	0.000186	CcSEcCtD
Rivaroxaban—Dyspnoea—Epirubicin—breast cancer	3.32e-05	0.000185	CcSEcCtD
Rivaroxaban—Nausea—Docetaxel—breast cancer	3.28e-05	0.000183	CcSEcCtD
Rivaroxaban—Feeling abnormal—Methotrexate—breast cancer	3.28e-05	0.000183	CcSEcCtD
Rivaroxaban—Dyspepsia—Epirubicin—breast cancer	3.28e-05	0.000183	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Methotrexate—breast cancer	3.25e-05	0.000181	CcSEcCtD
Rivaroxaban—Hypotension—Doxorubicin—breast cancer	3.22e-05	0.000179	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Epirubicin—breast cancer	3.21e-05	0.000179	CcSEcCtD
Rivaroxaban—Fatigue—Epirubicin—breast cancer	3.21e-05	0.000179	CcSEcCtD
Rivaroxaban—Pain—Epirubicin—breast cancer	3.18e-05	0.000177	CcSEcCtD
Rivaroxaban—Constipation—Epirubicin—breast cancer	3.18e-05	0.000177	CcSEcCtD
Rivaroxaban—Nausea—Capecitabine—breast cancer	3.17e-05	0.000177	CcSEcCtD
Rivaroxaban—Urticaria—Methotrexate—breast cancer	3.16e-05	0.000176	CcSEcCtD
Rivaroxaban—Abdominal pain—Methotrexate—breast cancer	3.14e-05	0.000175	CcSEcCtD
Rivaroxaban—Dyspnoea—Doxorubicin—breast cancer	3.07e-05	0.000171	CcSEcCtD
Rivaroxaban—Feeling abnormal—Epirubicin—breast cancer	3.07e-05	0.000171	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Epirubicin—breast cancer	3.04e-05	0.00017	CcSEcCtD
Rivaroxaban—Dyspepsia—Doxorubicin—breast cancer	3.03e-05	0.000169	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Doxorubicin—breast cancer	2.97e-05	0.000166	CcSEcCtD
Rivaroxaban—Fatigue—Doxorubicin—breast cancer	2.97e-05	0.000165	CcSEcCtD
Rivaroxaban—Urticaria—Epirubicin—breast cancer	2.96e-05	0.000165	CcSEcCtD
Rivaroxaban—Constipation—Doxorubicin—breast cancer	2.94e-05	0.000164	CcSEcCtD
Rivaroxaban—Pain—Doxorubicin—breast cancer	2.94e-05	0.000164	CcSEcCtD
Rivaroxaban—Abdominal pain—Epirubicin—breast cancer	2.94e-05	0.000164	CcSEcCtD
Rivaroxaban—Hypersensitivity—Methotrexate—breast cancer	2.93e-05	0.000163	CcSEcCtD
Rivaroxaban—Asthenia—Methotrexate—breast cancer	2.85e-05	0.000159	CcSEcCtD
Rivaroxaban—Feeling abnormal—Doxorubicin—breast cancer	2.84e-05	0.000158	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Doxorubicin—breast cancer	2.82e-05	0.000157	CcSEcCtD
Rivaroxaban—Pruritus—Methotrexate—breast cancer	2.81e-05	0.000157	CcSEcCtD
Rivaroxaban—Hypersensitivity—Epirubicin—breast cancer	2.74e-05	0.000153	CcSEcCtD
Rivaroxaban—Urticaria—Doxorubicin—breast cancer	2.74e-05	0.000152	CcSEcCtD
Rivaroxaban—Abdominal pain—Doxorubicin—breast cancer	2.72e-05	0.000152	CcSEcCtD
Rivaroxaban—Diarrhoea—Methotrexate—breast cancer	2.72e-05	0.000152	CcSEcCtD
Rivaroxaban—Asthenia—Epirubicin—breast cancer	2.67e-05	0.000149	CcSEcCtD
Rivaroxaban—Pruritus—Epirubicin—breast cancer	2.63e-05	0.000147	CcSEcCtD
Rivaroxaban—Dizziness—Methotrexate—breast cancer	2.63e-05	0.000147	CcSEcCtD
Rivaroxaban—Diarrhoea—Epirubicin—breast cancer	2.55e-05	0.000142	CcSEcCtD
Rivaroxaban—Hypersensitivity—Doxorubicin—breast cancer	2.54e-05	0.000141	CcSEcCtD
Rivaroxaban—Vomiting—Methotrexate—breast cancer	2.53e-05	0.000141	CcSEcCtD
Rivaroxaban—Rash—Methotrexate—breast cancer	2.51e-05	0.00014	CcSEcCtD
Rivaroxaban—Dermatitis—Methotrexate—breast cancer	2.5e-05	0.00014	CcSEcCtD
Rivaroxaban—Headache—Methotrexate—breast cancer	2.49e-05	0.000139	CcSEcCtD
Rivaroxaban—Asthenia—Doxorubicin—breast cancer	2.47e-05	0.000138	CcSEcCtD
Rivaroxaban—Dizziness—Epirubicin—breast cancer	2.46e-05	0.000137	CcSEcCtD
Rivaroxaban—Pruritus—Doxorubicin—breast cancer	2.44e-05	0.000136	CcSEcCtD
Rivaroxaban—Vomiting—Epirubicin—breast cancer	2.37e-05	0.000132	CcSEcCtD
Rivaroxaban—Nausea—Methotrexate—breast cancer	2.36e-05	0.000132	CcSEcCtD
Rivaroxaban—Diarrhoea—Doxorubicin—breast cancer	2.36e-05	0.000131	CcSEcCtD
Rivaroxaban—Rash—Epirubicin—breast cancer	2.35e-05	0.000131	CcSEcCtD
Rivaroxaban—Dermatitis—Epirubicin—breast cancer	2.34e-05	0.000131	CcSEcCtD
Rivaroxaban—Headache—Epirubicin—breast cancer	2.33e-05	0.00013	CcSEcCtD
Rivaroxaban—Dizziness—Doxorubicin—breast cancer	2.28e-05	0.000127	CcSEcCtD
Rivaroxaban—Nausea—Epirubicin—breast cancer	2.21e-05	0.000123	CcSEcCtD
Rivaroxaban—Vomiting—Doxorubicin—breast cancer	2.19e-05	0.000122	CcSEcCtD
Rivaroxaban—Rash—Doxorubicin—breast cancer	2.17e-05	0.000121	CcSEcCtD
Rivaroxaban—Dermatitis—Doxorubicin—breast cancer	2.17e-05	0.000121	CcSEcCtD
Rivaroxaban—Headache—Doxorubicin—breast cancer	2.16e-05	0.00012	CcSEcCtD
Rivaroxaban—Nausea—Doxorubicin—breast cancer	2.05e-05	0.000114	CcSEcCtD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	1.19e-05	0.000132	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—NOS3—breast cancer	1.17e-05	0.00013	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	1.16e-05	0.000129	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTA2—breast cancer	1.16e-05	0.000129	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GPX2—breast cancer	1.16e-05	0.000129	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HADHB—breast cancer	1.16e-05	0.000129	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GPI—breast cancer	1.16e-05	0.000129	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.15e-05	0.000128	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GPX4—breast cancer	1.15e-05	0.000128	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SULT1A1—breast cancer	1.15e-05	0.000128	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SYNJ2—breast cancer	1.14e-05	0.000126	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1.13e-05	0.000126	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1.13e-05	0.000126	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTA1—breast cancer	1.12e-05	0.000125	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—IDH1—breast cancer	1.12e-05	0.000125	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.12e-05	0.000125	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NAT2—breast cancer	1.11e-05	0.000123	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALDH7A1—breast cancer	1.11e-05	0.000123	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALDH1A1—breast cancer	1.11e-05	0.000123	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.1e-05	0.000122	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.09e-05	0.000121	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CB—breast cancer	1.08e-05	0.00012	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—breast cancer	1.07e-05	0.000119	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.07e-05	0.000119	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PHGDH—breast cancer	1.06e-05	0.000118	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—FHL2—breast cancer	1.06e-05	0.000118	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—UMPS—breast cancer	1.06e-05	0.000118	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADSL—breast cancer	1.06e-05	0.000118	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NME1—breast cancer	1.06e-05	0.000118	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NDUFS3—breast cancer	1.06e-05	0.000117	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	1.05e-05	0.000117	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—BRIP1—breast cancer	1.04e-05	0.000115	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HPSE—breast cancer	1.04e-05	0.000115	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LDHB—breast cancer	1.04e-05	0.000115	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	1.03e-05	0.000114	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.01e-05	0.000113	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CHST9—breast cancer	9.94e-06	0.00011	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	9.88e-06	0.00011	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTA3—breast cancer	9.86e-06	0.000109	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ABCC1—breast cancer	9.86e-06	0.000109	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMMR—breast cancer	9.86e-06	0.000109	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MED12—breast cancer	9.74e-06	0.000108	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—DPYD—breast cancer	9.74e-06	0.000108	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALDOA—breast cancer	9.59e-06	0.000106	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARGC1B—breast cancer	9.55e-06	0.000106	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	9.48e-06	0.000105	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—COX11—breast cancer	9.42e-06	0.000105	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTEN—breast cancer	9.36e-06	0.000104	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	9.35e-06	0.000104	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NCOA3—breast cancer	9.31e-06	0.000103	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC2A2—breast cancer	9.24e-06	0.000103	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	9.09e-06	0.000101	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	9.07e-06	0.000101	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCG2—breast cancer	9.05e-06	0.000101	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CPT1A—breast cancer	9.05e-06	0.000101	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MTR—breast cancer	9.05e-06	0.000101	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CA9—breast cancer	9.01e-06	0.0001	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTA4—breast cancer	9.01e-06	0.0001	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	8.89e-06	9.88e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HPGDS—breast cancer	8.88e-06	9.86e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HBA1—breast cancer	8.82e-06	9.8e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTA2—breast cancer	8.78e-06	9.75e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GPX2—breast cancer	8.78e-06	9.75e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GPX4—breast cancer	8.68e-06	9.63e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SULT1A1—breast cancer	8.68e-06	9.63e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SHMT1—breast cancer	8.62e-06	9.57e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CDA—breast cancer	8.62e-06	9.57e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTT1—breast cancer	8.61e-06	9.56e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ACHE—breast cancer	8.61e-06	9.56e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—IDH1—breast cancer	8.48e-06	9.41e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTA1—breast cancer	8.48e-06	9.41e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	8.47e-06	9.4e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	8.4e-06	9.33e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NAT2—breast cancer	8.38e-06	9.3e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC2A5—breast cancer	8.3e-06	9.21e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLCO1B1—breast cancer	8.3e-06	9.21e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP17A1—breast cancer	8.15e-06	9.05e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ENO1—breast cancer	8.07e-06	8.96e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS1—breast cancer	8.07e-06	8.96e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APRT—breast cancer	8.01e-06	8.9e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2D6—breast cancer	7.91e-06	8.79e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NCOA2—breast cancer	7.77e-06	8.62e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	7.72e-06	8.57e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ESRRA—breast cancer	7.53e-06	8.36e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ANGPTL4—breast cancer	7.53e-06	8.36e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—FASN—breast cancer	7.53e-06	8.36e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—BCHE—breast cancer	7.5e-06	8.33e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	7.47e-06	8.29e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC5A5—breast cancer	7.41e-06	8.23e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MED12—breast cancer	7.35e-06	8.16e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—DPYD—breast cancer	7.35e-06	8.16e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALDOA—breast cancer	7.23e-06	8.03e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NQO1—breast cancer	7.16e-06	7.95e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC2A1—breast cancer	7.16e-06	7.95e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GPI—breast cancer	7.14e-06	7.93e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HADHB—breast cancer	7.14e-06	7.93e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NCOA3—breast cancer	7.02e-06	7.8e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP3A4—breast cancer	6.98e-06	7.75e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC2A2—breast cancer	6.97e-06	7.74e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP1B1—breast cancer	6.86e-06	7.62e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MTR—breast cancer	6.83e-06	7.58e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CPT1A—breast cancer	6.83e-06	7.58e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ABCG2—breast cancer	6.83e-06	7.58e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDH1A1—breast cancer	6.81e-06	7.56e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDH7A1—breast cancer	6.81e-06	7.56e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HSP90AA1—breast cancer	6.73e-06	7.47e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HPGDS—breast cancer	6.7e-06	7.44e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HBA1—breast cancer	6.66e-06	7.39e-05	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CA—breast cancer	6.6e-06	7.33e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NCOA1—breast cancer	6.55e-06	7.27e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—FHL2—breast cancer	6.53e-06	7.25e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADSL—breast cancer	6.53e-06	7.25e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—UMPS—breast cancer	6.53e-06	7.25e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NME1—breast cancer	6.53e-06	7.25e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PHGDH—breast cancer	6.53e-06	7.25e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ACHE—breast cancer	6.5e-06	7.21e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTT1—breast cancer	6.5e-06	7.21e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—STK11—breast cancer	6.45e-06	7.16e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP19A1—breast cancer	6.45e-06	7.16e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HPSE—breast cancer	6.41e-06	7.11e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LDHB—breast cancer	6.41e-06	7.11e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—BRIP1—breast cancer	6.41e-06	7.11e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	6.31e-06	7e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP17A1—breast cancer	6.15e-06	6.83e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS1—breast cancer	6.09e-06	6.76e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ENO1—breast cancer	6.09e-06	6.76e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCC1—breast cancer	6.07e-06	6.74e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTA3—breast cancer	6.07e-06	6.74e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMMR—breast cancer	6.07e-06	6.74e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—COMT—breast cancer	6e-06	6.66e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2D6—breast cancer	5.97e-06	6.63e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTP1—breast cancer	5.97e-06	6.63e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HMOX1—breast cancer	5.89e-06	6.54e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARGC1B—breast cancer	5.88e-06	6.53e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ITPR1—breast cancer	5.87e-06	6.52e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NCOA2—breast cancer	5.86e-06	6.51e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	5.69e-06	6.32e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—FASN—breast cancer	5.68e-06	6.31e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—BCHE—breast cancer	5.66e-06	6.28e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCB1—breast cancer	5.65e-06	6.27e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC5A5—breast cancer	5.59e-06	6.21e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CA9—breast cancer	5.55e-06	6.17e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTA4—breast cancer	5.55e-06	6.17e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—TYMS—breast cancer	5.55e-06	6.16e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLA2G4A—breast cancer	5.49e-06	6.09e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NCOR1—breast cancer	5.49e-06	6.09e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTM1—breast cancer	5.49e-06	6.09e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTA2—breast cancer	5.41e-06	6.01e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GPX2—breast cancer	5.41e-06	6.01e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NQO1—breast cancer	5.4e-06	6e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC2A1—breast cancer	5.4e-06	6e-05	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—AKT1—breast cancer	5.39e-06	5.99e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GPX4—breast cancer	5.35e-06	5.94e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SULT1A1—breast cancer	5.35e-06	5.94e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP3A4—breast cancer	5.27e-06	5.85e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GPX1—breast cancer	5.25e-06	5.83e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—IDH1—breast cancer	5.22e-06	5.8e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTA1—breast cancer	5.22e-06	5.8e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP1A1—breast cancer	5.2e-06	5.77e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP1B1—breast cancer	5.18e-06	5.75e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NAT2—breast cancer	5.16e-06	5.73e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ERCC2—breast cancer	5.16e-06	5.73e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	5.15e-06	5.72e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HSP90AA1—breast cancer	5.08e-06	5.64e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NCOA1—breast cancer	4.94e-06	5.48e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—STK11—breast cancer	4.87e-06	5.4e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP19A1—breast cancer	4.87e-06	5.4e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MTHFR—breast cancer	4.85e-06	5.38e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MED12—breast cancer	4.53e-06	5.03e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—DPYD—breast cancer	4.53e-06	5.03e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—COMT—breast cancer	4.53e-06	5.02e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTP1—breast cancer	4.5e-06	5e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CAV1—breast cancer	4.47e-06	4.96e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDOA—breast cancer	4.46e-06	4.95e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMOX1—breast cancer	4.44e-06	4.93e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ITPR1—breast cancer	4.43e-06	4.92e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NCOA3—breast cancer	4.33e-06	4.8e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC2A2—breast cancer	4.3e-06	4.77e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CPT1A—breast cancer	4.21e-06	4.67e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCG2—breast cancer	4.21e-06	4.67e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MTR—breast cancer	4.21e-06	4.67e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—TYMS—breast cancer	4.19e-06	4.65e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NCOR1—breast cancer	4.14e-06	4.6e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLA2G4A—breast cancer	4.14e-06	4.6e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTM1—breast cancer	4.14e-06	4.6e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HPGDS—breast cancer	4.13e-06	4.58e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HBA1—breast cancer	4.1e-06	4.55e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CG—breast cancer	4.07e-06	4.52e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ACHE—breast cancer	4e-06	4.44e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTT1—breast cancer	4e-06	4.44e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GPX1—breast cancer	3.96e-06	4.4e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP1A1—breast cancer	3.92e-06	4.36e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ERCC2—breast cancer	3.89e-06	4.32e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP17A1—breast cancer	3.79e-06	4.21e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ENO1—breast cancer	3.75e-06	4.17e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS1—breast cancer	3.75e-06	4.17e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2D6—breast cancer	3.68e-06	4.08e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MTHFR—breast cancer	3.66e-06	4.06e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NCOA2—breast cancer	3.61e-06	4.01e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CD—breast cancer	3.58e-06	3.98e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALB—breast cancer	3.53e-06	3.92e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—FASN—breast cancer	3.5e-06	3.89e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—BCHE—breast cancer	3.49e-06	3.87e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC5A5—breast cancer	3.45e-06	3.82e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NOS3—breast cancer	3.38e-06	3.75e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CAV1—breast cancer	3.37e-06	3.75e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC2A1—breast cancer	3.33e-06	3.69e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NQO1—breast cancer	3.33e-06	3.69e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP1B1—breast cancer	3.19e-06	3.54e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.13e-06	3.47e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CB—breast cancer	3.12e-06	3.46e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—breast cancer	3.09e-06	3.43e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CG—breast cancer	3.07e-06	3.41e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NCOA1—breast cancer	3.04e-06	3.38e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP19A1—breast cancer	3e-06	3.33e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—STK11—breast cancer	3e-06	3.33e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—COMT—breast cancer	2.79e-06	3.1e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTP1—breast cancer	2.78e-06	3.08e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMOX1—breast cancer	2.74e-06	3.04e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ITPR1—breast cancer	2.73e-06	3.03e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CD—breast cancer	2.7e-06	3e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTEN—breast cancer	2.7e-06	2.99e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALB—breast cancer	2.67e-06	2.96e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCB1—breast cancer	2.63e-06	2.92e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—TYMS—breast cancer	2.58e-06	2.86e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NOS3—breast cancer	2.55e-06	2.83e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.55e-06	2.83e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTM1—breast cancer	2.55e-06	2.83e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NCOR1—breast cancer	2.55e-06	2.83e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GPX1—breast cancer	2.44e-06	2.71e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP1A1—breast cancer	2.42e-06	2.68e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ERCC2—breast cancer	2.4e-06	2.66e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CB—breast cancer	2.36e-06	2.61e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—breast cancer	2.33e-06	2.59e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MTHFR—breast cancer	2.25e-06	2.5e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CAV1—breast cancer	2.08e-06	2.31e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTEN—breast cancer	2.04e-06	2.26e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CA—breast cancer	1.9e-06	2.11e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CG—breast cancer	1.89e-06	2.1e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CD—breast cancer	1.66e-06	1.85e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALB—breast cancer	1.64e-06	1.82e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NOS3—breast cancer	1.57e-06	1.75e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AKT1—breast cancer	1.55e-06	1.73e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CB—breast cancer	1.45e-06	1.61e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—breast cancer	1.44e-06	1.6e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CA—breast cancer	1.44e-06	1.59e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTEN—breast cancer	1.25e-06	1.39e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AKT1—breast cancer	1.17e-06	1.3e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CA—breast cancer	8.85e-07	9.82e-06	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AKT1—breast cancer	7.23e-07	8.02e-06	CbGpPWpGaD
